स्विट्ज़रलैंड -
फ़्रेंच -
Swissmedic (Swiss Agency for Therapeutic Products)
miacalcic mite 100 spray nasal
future health pharma gmbh - calcitoninum salmonis - spray nasal - calcitoninum salmonis 100 u.i., natrii chloridum, acidum hydrochloridum 25 per centum, benzalkonii chloridum 0.009 mg, aqua purificata, ad solutionem pro dosi. - osteoporoseprävention, morbus paget, neurodystrophische störungen - synthetika
स्विट्ज़रलैंड -
फ़्रेंच -
Swissmedic (Swiss Agency for Therapeutic Products)
miacalcic 200 spray nasal
future health pharma gmbh - calcitoninum salmonis - spray nasal - calcitoninum salmonis 200 u.i., natrii chloridum, acidum hydrochloridum 25 per centum, benzalkonii chloridum 0.009 mg, aqua purificata, ad solutionem pro dosi. - osteoporoseprävention, morbus paget, neurodystrophische störungen - synthetika
स्विट्ज़रलैंड -
फ़्रेंच -
Swissmedic (Swiss Agency for Therapeutic Products)
miacalcic 100 solution injectable
future health pharma gmbh - calcitoninum salmonis - solution injectable - calcitoninum salmonis 100 u.i., natrii acetas trihydricus, acidum aceticum glaciale, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.29 mg. - osteoporoseprävention, morbus paget, hyperkalzämie, neurodystrophische störungen - synthetika
स्विट्ज़रलैंड -
फ़्रेंच -
Swissmedic (Swiss Agency for Therapeutic Products)
miacalcic 50 solution injectable
future health pharma gmbh - calcitoninum salmonis - solution injectable - calcitoninum salmonis 50 u.i., natrii acetas trihydricus, acidum aceticum glaciale, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.29 mg. - osteoporoseprävention, morbus paget, hyperkalzämie, neurodystrophische störungen - synthetika